Targeting Mitochondrial Quality Control as a Therapeutic Strategy for Cancer
Time: 10:30 am
day: Day Two
Details:
- Uncovering novel modulators of mitochondrial protein quality control as therapy for relapsed/refractory diffuse large B-cell lymphomas
- Explore the key challenges in developing agents directed against mitochondria for cancer therapeutics
- Discover novel clinical biomarkers related to mitochondrial biology
